5050
S. Imuta et al. / Tetrahedron Letters 44 (2003) 5047–5051
3. (a) Kondo, S.; Horiuchi, Y.; Hamada, M.; Takeuchi, T.;
Umezawa, H. J. Antibiot. 1979, 32, 1069–1071; (b) Hori,
M.; Suzukake, K.; Ishikawa, C.; Asakura, H.; Umezawa,
H. J. Antibiot. 1981, 34, 465–468.
4. (a) Ishizuka, M.; Fakasawa, S.; Masuda, T.; Sato, J.;
Kanbayashi, N.; Takeuchi, T.; Umezawa, H. J. Antibiot.
1980, 33, 1054–1062; (b) Tabira, T.; Da-Lin, Y.; Yama-
mura, T.; Aoyagi, T. Proc. Jpn. Acad. Ser. B 1987, 63,
127–130.
5. (a) Yoshioka, M.; Nakai, H.; Ohno, M. J. Am. Chem.
Soc. 1984, 106, 1133–1135; Heterocycles 1984, 21, 151–
165; (b) Askin D.; Angst, C.; Danishefsky, S. J. J. Org.
Chem. 1985, 50, 5005–5007; J. Org. Chem. 1987, 52,
622–635; (c) Rahman, M. A.; Fraser-Reid, B. J. Am.
Chem. Soc. 1985, 107, 5576–5578; (d) Kozikowski, A. P.;
Konoike, T.; Nieduzak, T. R. J. Chem. Soc., Chem.
Commun. 1986, 1350–1352; (e) Kozikowski, A. P.;
Nieduzak, T. R.; Konoike, T.; Springer, J. P. J. Am.
Chem. Soc. 1987, 109, 5167–5175; (f) Garigipati, R. S.;
Tschaen, D. M.; Weinreb, S. M. J. Am. Chem. Soc. 1985,
107, 7790–7792; J. Am. Chem. Soc. 1990, 112, 3475–3482;
(g) Ward, D. E.; Kaller, B. F. Tetrahedron Lett. 1993, 34,
407–410; J. Org. Chem. 1994, 59, 4230–4238; (h) Ward,
D. E.; Yuanzhu, G.; Kaller, B. F. J. Org. Chem. 1996, 61,
5498–5505.
6. (a) Munakata, T. Yakugaku Zasshi 1981, 101, 138–147;
(b) Munakata, T.; Okumoto, T. Chem. Pharm. Bull.
1981, 29, 891–894; (c) Nishimura, Y.; Kondo, S.;
Takeuchi, T. J. Antibiot. 1992, 45, 735–741; (d) Adachi,
M.; Nishimura, Y.; Kondo, S.; Takeuchi, T. J. Antibiot.
1998, 51, 202–209; (e) Adachi, H.; Nishimura, Y.;
Takeuchi, T. J. Antibiot. 2002, 55, 92–98.
7. For a review, see: (a) Taylor, R. J. K. Synthesis 1985,
364–392. We accomplished the synthesis of CD ring unit
of paclitaxel using a three-component coupling strategy,
see: (b) Momose, T.; Setoguchi, M.; Fujita, T.; Tamura,
H.; Chida, N. Chem. Commun. 2000, 2237–2238.
8. (a) Ferrier, R. J.; Middleton, S. Chem. Rev. 1993, 93,
2779–2831; Top. Curr. Chem. 2001, 215, 277–291. For
recent applications of Ferrier’s carbocyclization in natu-
ral product synthesis, see: (b) Takahashi, H.; Kittaka, H.;
Ikegami, S. J. Org. Chem. 2001, 66, 2705–2716; (c) Taille-
fumier, C.; Chapleur, Y. Can. J. Chem. 2000, 78, 708–
722; (d) Amano, S.; Ogawa, N.; Ohtsuka, M.; Ogawa, S.;
Chida, N. Tetrahedron 1999, 55, 3855–3870.
9. Vis, E.; Karrer, P. Helv. Chim. Acta 1954, 46, 378–381.
10. All new compounds described in this letter were isolated
as a single compound by chromatographic separation
and/or recrystallization, and fully characterized by 300
MHz 1H NMR, 75 MHz 13C NMR, IR, and mass
spectrometric and/or elemental analyses. The stereo-
chemistries were assigned based on NMR experiments
(COSY, decoupling, and/or NOE).
Scheme 5.
spectral data and the absolute value of [h]D of (−)-6
{[h]2D0 −22 (c 0.80, CHCl3)} were fully identical with
those of (+)-6 {[h]2D3 +22 (c 0.94, CHCl3)}, representing
a formal synthesis of (+)-actinobolin 1.
In summary, a new synthetic route to both (−)- and
(+)-actinobolin starting from
D-glucose has been estab-
lished. This work demonstrated that the methodology
involving the three-component coupling reaction on
chiral cyclohexenones, derived from carbohydrates by
way of Ferrier’s carbocyclization, is effective for the
chiral and stereoselective synthesis of natural products
possessing highly oxygenated cyclohexane moieties.
Acknowledgements
We thank Dr. Y. Nishimura (Institute of Microbial
Chemistry, Tokyo, Japan) for a generous gift of natural
actinobolin.
References
1. (a) Haskell, T. H.; Bartz, Q. R. Anibiot. Ann. 1958–1959,
505–509; (b) Fusari, S. A.; Machamer, H. E. Antibiot.
Ann. 1958–1959, 510–514; (c) Pittillo, R. F.; Fisher, M.
W.; McAlpine, R. J.; Thompson, P. E.; Ehrlich, J.
Anibiot. Ann. 1958–1959, 497–504; (d) Merker, P. C.;
Woolley, G. W. Antibiot. Ann. 1958–1959, 515–517; (e)
Teller, M. N.; Merker, P. C.; Palm, J. E.; Woolley, G. W.
Antibiot. Ann. 1958–1959, 518–521.
2. (a) Struck, R. F.; Thorpe, W. C.; Coburn, W. C., Jr.;
Shealy, Y. F. Tetrahedron Lett. 1967, 1589–1595; (b)
Antosz, F. J.; Nelson, D. B.; Herald, D. L., Jr.; Munk,
M. E. J. Am. Chem. Soc. 1970, 92, 4933–4942; (c)
Wetherington, J. B.; Moncrief, J. W. Acta Crystallogr.
1975, B31, 501–511.
11. Chida, N.; Ohtsuka, M.; Ogura, K.; Ogawa, S. Bull.
Chem. Soc. Jpn. 1991, 64, 2118–2121.
12. Use of acetate buffer (pH 4.8, 0.1 M solution) suppressed
the partial hydrolysis of O-TBS group during the reac-
tion, and greatly improved the cyclization yields.
13. Nakajima, N.; Horita, K.; Abe, R.; Yonemitsu, O. Tetra-
hedron Lett. 1988, 29, 4139–4142.
14. Further investigation of the interesting aldol process of
the intermediate enolate 6% with various aldehydes is
underway and the results will be reported in a full
account.